Omid Asbaghi, Mohammad Zamani, Mahlagha Nikbaf-Shandiz, Farideh Shiraseb, Fatemeh Gholami, Mahtab Zarei, Amir Mehdi Hosseini, Maryam Nadery
Journal: Frontiers in nutrition 2022;9():1055517
PMID: 36570145
Cardiovascular disease (CVD) is a leading cause of death and disability around the world and presents a significant burden for healthcare systems. CVD has many risk factors, including diet and lifestyle habits. Hence, favourable interventions in those areas can help prevent and manage CVD. This systematic review examined the effects of saffron crocus on cardiovascular risk factors. Saffron is derived from the flowering plant Saffron Crocus (Crocus sativus). It contains many active compounds such as crocetin, crocin, picrocrocin, and safrana, which in various studies demonstrated positive effects on blood glucose levels, insulin resistance and sensitivity and blood fats, besides also having antioxidant and anti-inflammatory qualities. Yet, results were not always consistent, and hence this meta-analysis gathered evidence from 32 randomised controlled trials (RCTs) which included a total of 1674 subjects and investigated the effect of saffron supplements on cardiovascular risk factors such as blood fats, blood glucose control, blood pressure, anthropometric measures, and inflammatory markers. In conclusion, the analysis showed that saffron supplementation aided the reduction of some inflammatory markers (CRP, TNF-α), had favourable effects on antioxidant capacity, reduced blood fats except high-density lipoprotein (HDL), enhanced blood control and insulin sensitivity, reduced blood pressure and was linked to a reduction in waist circumference but with no significant effect on weight itself, BMI or fat mass. The authors discussed how their results relate to previous research and what underlying mechanisms can explain the effects or discrepancies. Given the positive results, saffron presents itself as a promising supplement and adjunct therapy for managing CVD and its risk factors.
INTRODUCTION
Cardiovascular disease (CVD) is one of the leading causes of death and disability in the world and is estimated to involve more people in the next years. It is said that alternative remedies such as herbs can be used to manage the complications of this disease. For this reason, we aimed to conduct this meta-analysis to systematically assess and summarize the effects of saffron supplementation as an important herb on cardiovascular risk factors in adults.
METHODS
A systematic search was done in PubMed, Scopus, and Web of Science to find eligible articles up to September 2022. Randomized controlled trials (RCTs) that evaluated the effects of saffron on lipid profiles, glycemic control, blood pressure, anthropometric measures, and inflammatory markers were included. In the meta-analysis, 32 studies were taken into account ( = 1674).
RESULTS
Consumption of saffron significantly decreased triglyceride (TG) (WMD = -8.81 mg/dl, 95%CI: -14.33, -3.28; = 0.002), total cholesterol (TC) (WMD = -6.87 mg/dl, 95%CI: -11.19, -2.56; = 0.002), low density lipoprotein (LDL) (WMD = -6.71 mg/dl, 95%CI: -10.51, -2.91; = 0.001), ( = 0.660), fasting blood glucose (FBG) level (WMD = -7.59 mg/dl, 95%CI: -11.88, -3.30; = 0.001), HbA1c (WMD = -0.18%, 95%CI: -0.21, -0.07; < 0.001), homeostasis model assessment-insulin resistance (HOMA-IR) (WMD = -0.49, 95%CI: -0.89, -0.09; = 0.016), systolic blood pressure (SBP) (WMD = -3.42 mmHg, 95%CI: -5.80, -1.04; = 0.005), tumor necrosis factor α (TNF-α) (WMD = -2.54 pg/ml, 95%CI: -4.43, -0.65; = 0.008), waist circumference (WC) (WMD = -1.50 cm; 95%CI: -2.83, -0.18; = 0.026), malondialdehyde (MDA) (WMD = -1.50 uM/L, 95%CI: -2.42, -0.57; = 0.001), and alanine transferase (ALT) (WMD = -2.16 U/L, 95%CI: -4.10, -0.23; = 0.028). Also, we observed that saffron had an increasing effect on total antioxidant capacity (TAC) (WMD = 0.07 mM/L, 95%CI: 0.01, 0.13; = 0.032). There was linear regression between FBG and the duration of saffron intake. Additionally, the non-linear dose-response analysis has shown a significant association of saffron intervention with HDL ( = 0.049), HOMA-IR ( = 0.002), weight ( = 0.036), ALP ( = 0.016), FBG ( = 0.011), HbA1c ( = 0.002), and TNF-α ( = 0.042). A non-linear association between the length of the intervention and the level of HDL and DBP was also found.
DISCUSSION
That seems saffron could effectively improve TG, TC, LDL, FBG, HbA1c, HOMA-IR, SBP, CRP, TNF-α, WC, MDA, TAC, and ALT.
Copyright © 2022 Zamani, Zarei, Nikbaf-Shandiz, Gholami, Hosseini, Nadery, Shiraseb and Asbaghi.
Full Text Sources:
Miscellaneous:
Research Materials:
© Copyright 2026, Nutrition Evidence
NED wishes to thank the following organisations for their support:
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.